A recent funding announcement from the federal government supports a trio of initiatives at the University of Saskatchewan.
The first is research at VIDO-Intervac on the U of S campus, looking into vaccines for infectious diseases like tuberculosis and pandemic influenza.
The second project to receive funds is the Canadian Light Source, with biomedical imaging and therapy to look at advancing cancer therapy and to treat osteoporosis.
A third, for SuperDARN Canada is continuing the study through radar of how solar wind influences the earth’s upper atmosphere .
The three U of S research centres will receive almost $69-million in federal funding, collectively.